Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

1.

Effect of rapid cessation of enzyme replacement therapy: a report of 5 cases and a review of the literature.

Jurecka A, Żuberuber Z, Opoka-Winiarska V, Węgrzyn G, Tylki-Szymańska A.

Mol Genet Metab. 2012 Nov;107(3):508-12. doi: 10.1016/j.ymgme.2012.08.013. Epub 2012 Aug 17. Review.

PMID:
22926198
[PubMed - indexed for MEDLINE]
2.

First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: case observations from the Hunter Outcome Survey (HOS).

Alcalde-Martín C, Muro-Tudelilla JM, Cancho-Candela R, Gutiérrez-Solana LG, Pintos-Morell G, Martí-Herrero M, Munguira-Aguado P, Galán-Gómez E.

Eur J Med Genet. 2010 Nov-Dec;53(6):371-7. doi: 10.1016/j.ejmg.2010.07.013. Epub 2010 Aug 10.

PMID:
20709629
[PubMed - indexed for MEDLINE]
3.

Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II.

Schulze-Frenking G, Jones SA, Roberts J, Beck M, Wraith JE.

J Inherit Metab Dis. 2011 Feb;34(1):203-8. doi: 10.1007/s10545-010-9215-2. Epub 2010 Oct 27.

PMID:
20978944
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Effects of idursulfase enzyme replacement therapy for Mucopolysaccharidosis type II when started in early infancy: comparison in two siblings.

Tajima G, Sakura N, Kosuga M, Okuyama T, Kobayashi M.

Mol Genet Metab. 2013 Mar;108(3):172-7. doi: 10.1016/j.ymgme.2012.12.010. Epub 2013 Jan 9.

PMID:
23375472
[PubMed - indexed for MEDLINE]
5.

Management of infusion-related reactions to enzyme replacement therapy in a cohort of patients with mucopolysaccharidosis disorders.

Miebach E.

Int J Clin Pharmacol Ther. 2009;47 Suppl 1:S100-6.

PMID:
20040319
[PubMed - indexed for MEDLINE]
6.

The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders.

Wyatt K, Henley W, Anderson L, Anderson R, Nikolaou V, Stein K, Klinger L, Hughes D, Waldek S, Lachmann R, Mehta A, Vellodi A, Logan S.

Health Technol Assess. 2012;16(39):1-543. doi: 10.3310/hta16390.

PMID:
23089251
[PubMed - indexed for MEDLINE]
Free Article
7.

Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II.

Higuchi T, Shimizu H, Fukuda T, Kawagoe S, Matsumoto J, Shimada Y, Kobayashi H, Ida H, Ohashi T, Morimoto H, Hirato T, Nishino K, Eto Y.

Mol Genet Metab. 2012 Sep;107(1-2):122-8. doi: 10.1016/j.ymgme.2012.05.005. Epub 2012 May 18.

PMID:
22704483
[PubMed - indexed for MEDLINE]
8.

The role of enzyme replacement therapy in severe Hunter syndrome-an expert panel consensus.

Muenzer J, Bodamer O, Burton B, Clarke L, Frenking GS, Giugliani R, Jones S, Rojas MV, Scarpa M, Beck M, Harmatz P.

Eur J Pediatr. 2012 Jan;171(1):181-8. doi: 10.1007/s00431-011-1606-3. Epub 2011 Oct 29.

PMID:
22037758
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: a perspective from the Hunter Outcome Survey (HOS).

Burton BK, Whiteman DA; HOS Investigators.

Mol Genet Metab. 2011 Jun;103(2):113-20. doi: 10.1016/j.ymgme.2011.02.018. Epub 2011 Mar 4.

PMID:
21439875
[PubMed - indexed for MEDLINE]
10.

Parental experience of enzyme replacement therapy for Hunter syndrome.

Buraczewska M, O'Leary D, Walsh O, Monavari A, Crushell E.

Ir Med J. 2013 Apr;106(4):120-2.

PMID:
23691848
[PubMed - indexed for MEDLINE]
11.

[Early response to idursulfase in a 31-year old male patient with Hunter syndrome].

Pérez-Calvo J, Bergua Sanclemente I, López Moreno MJ, Torralba Cabeza MÁ, Amores Arriaga B.

Rev Clin Esp. 2011 Jul-Aug;211(7):e42-5. doi: 10.1016/j.rce.2011.01.014. Epub 2011 Apr 27. Spanish.

PMID:
21524741
[PubMed - indexed for MEDLINE]
12.

Hunter syndrome in an 11-year old girl on enzyme replacement therapy with idursulfase: brain magnetic resonance imaging features and evolution.

Manara R, Rampazzo A, Cananzi M, Salviati L, Mardari R, Drigo P, Tomanin R, Gasparotto N, Priante E, Scarpa M.

J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S67-72. doi: 10.1007/s10545-009-9023-8. Epub 2010 Jan 6.

PMID:
20052546
[PubMed - indexed for MEDLINE]
13.

Mucopolysaccharidosis type II in females and response to enzyme replacement therapy.

Jurecka A, Krumina Z, Żuber Z, Różdżyńska-Świątkowska A, Kłoska A, Czartoryska B, Tylki-Szymańska A.

Am J Med Genet A. 2012 Feb;158A(2):450-4. doi: 10.1002/ajmg.a.34415. Epub 2012 Jan 13.

PMID:
22246721
[PubMed - indexed for MEDLINE]
14.

Japan Elaprase Treatment (JET) study: idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis II, MPS II).

Okuyama T, Tanaka A, Suzuki Y, Ida H, Tanaka T, Cox GF, Eto Y, Orii T.

Mol Genet Metab. 2010 Jan;99(1):18-25. doi: 10.1016/j.ymgme.2009.08.006. Epub .

PMID:
19773189
[PubMed - indexed for MEDLINE]
15.

Mucopolysaccharidosis Type II (Hunter Syndrome): clinical picture and treatment.

Beck M.

Curr Pharm Biotechnol. 2011 Jun;12(6):861-6. doi: 1389-2010/11 $58.00+.00. Review.

PMID:
21235446
[PubMed - indexed for MEDLINE]
16.

Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy.

Wraith JE, Scarpa M, Beck M, Bodamer OA, De Meirleir L, Guffon N, Meldgaard Lund A, Malm G, Van der Ploeg AT, Zeman J.

Eur J Pediatr. 2008 Mar;167(3):267-77. Epub 2007 Nov 23. Review.

PMID:
18038146
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

[Enzyme replacement therapy of lysosomal storage diseases].

Germain DP, Boucly C, Carlier RY, Caudron E, Charlier P, Colas F, Jabbour F, Martinez V, Mokhtari S, Orlikowski D, Pellegrini N, Perronne C, Prigent H, Rubinsztajn R, Benistan K.

Rev Med Interne. 2010 Dec;31 Suppl 2:S279-91. doi: 10.1016/S0248-8663(10)70028-X. French.

PMID:
21211680
[PubMed - indexed for MEDLINE]
18.

Oxidative stress in patients with mucopolysaccharidosis type II before and during enzyme replacement therapy.

Filippon L, Vanzin CS, Biancini GB, Pereira IN, Manfredini V, Sitta A, Peralba Mdo C, Schwartz IV, Giugliani R, Vargas CR.

Mol Genet Metab. 2011 Jun;103(2):121-7. doi: 10.1016/j.ymgme.2011.02.016. Epub 2011 Feb 26.

PMID:
21420339
[PubMed - indexed for MEDLINE]
19.

Phase I/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (Hunter syndrome).

Sohn YB, Cho SY, Park SW, Kim SJ, Ko AR, Kwon EK, Han SJ, Jin DK.

Orphanet J Rare Dis. 2013 Mar 18;8:42. doi: 10.1186/1750-1172-8-42.

PMID:
23497636
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type II.

Wraith JE.

Acta Paediatr Suppl. 2008 Apr;97(457):76-8. doi: 10.1111/j.1651-2227.2008.00661.x. Review.

PMID:
18339193
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk